As of July 2025, the Advisory Committee on Immunization Practices (ACIP) released new recommendations for influenza vaccination, stating that single-dose thimerosal-free formulations are now required for children up to 18, pregnant individuals, and all adults. While this new guidance may help strengthen public trust in immunization, it's important to consider how to implement it across patient populations, such as elderly, pediatric, pregnant, and immunocompromised groups. Joining Dr. Charles Turck to discuss practical strategies for protecting all patients under the new recommendations are Drs. Darvin Smith and Rob Danoff. Dr. Smith is an infectious disease specialist at San Mateo Medical Center in San Mateo, California, and Dr. Danoff is the Program Director of both the Family Medicine Residency and the Combined Family Medicine and Emergency Medicine Residency at Jefferson Health Northeast in Philadelphia, as well as a Clinical Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University.